By Adam Covitt, Vice President, Federal Equipment Company
In the post-blockbuster era, pharma’s major manufacturers are under pressure to increase the cost efficiency of their manufacturing operations and extend the service-life of their processing equipment. Equipment investment-recovery strategies that include a well-planned and executed redeployment process and the right partners can add flexibility and extend asset utilization across geographically dispersed operations.